View Older Stories

Aug 19, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)

Aug 18, 2025 04:15PM Iovance receives Health Canada approval for melanoma cell therapy

Aug 7, 2025 04:10PM Iovance Biotherapeutics (IOVA) Misses Q2 EPS by 5c, reiterates guidance

Jul 22, 2025 08:50AM Barclays Reiterates Overweight Rating on Replimune Group (REPL), PT $17, 'We see this as a clear positive for Iovance's Amtagvi'

Jul 15, 2025 04:39AM Citizens JMP Reiterates Market Perform Rating on Iovanace Biotherapeutics (IOVA)

Jul 15, 2025 03:30AM Goldman Sachs Double Downgrades Iovanace Biotherapeutics (IOVA) to Sell

Jul 14, 2025 07:30AM Iovance reports 49% response rate for Amtagvi in melanoma study

Jul 13, 2025 08:41AM Iovance Biotherapeutics Sued for Securities Law Violations - Investors Should Contact Faruqi & Faruqi for More Information - IOVA

Jul 11, 2025 10:16AM IOVA 3-DAY DEADLINE ALERT: Hagens Berman Reminds Iovance (IOVA) Investors of Pending Securities Class Action, Encourages Investors with Losses to Contact the Firm

Jul 11, 2025 07:46AM IOVA COURT DEADLINE: Iovance Biotherapeutics Investors with Losses are Reminded to Contact BFA Law prior to the July 14 Class Action Deadline

Jul 10, 2025 04:44PM IOVA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 14 Deadline in Securities Class Acti

Jul 9, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 9, 2025 03:46PM IOVA NOTIFICATION: Iovance Biotherapeutics Investors that Lost Money on their Investment are Notified to Contact BFA Law by July 14 Class Action Deadline

Jul 9, 2025 01:35PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 8, 2025 03:36PM IOVA NOTIFICATION: Iovance Biotherapeutics Investors that Lost Money on their Investment are Notified to Contact BFA Law by July 14 Class Action Deadline

Jul 7, 2025 08:15PM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 7, 2025 09:16AM IOVA SHAREHOLDER ALERT: Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure- Hagens Berman

Jul 7, 2025 07:33AM IOVA SHAREHOLDER NEWS: Iovance Biotherapeutics Investors that Incurred Losses are Urged to Contact BFA Law before the July 14 Class Action Deadline

Jul 6, 2025 10:30AM IOVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action

Jul 5, 2025 07:18AM IOVA SHAREHOLDER NOTICE: Iovance Biotherapeutics Investors are Notified to Contact BFA Law about the Pending Class Action Lawsuit by July 14

Jul 4, 2025 12:17PM IOVA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IOV

Jul 4, 2025 10:07AM Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA

Jul 3, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 3, 2025 08:36AM IOVA CLASS ACTION NEWS: BFA Law Notifies Iovance Biotherapeutics Investors with Losses to Contact the Firm by July 14 Legal Deadline

Jul 1, 2025 04:50PM IOVA 13-DAY DEADLINE ALERT: Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit - Hagens Berman

Jul 1, 2025 12:48PM IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Jul 1, 2025 11:02AM IOVA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Act

Jul 1, 2025 08:18AM IOVA CLASS NOTICE: Iovance Biotherapeutics Investors are Urged to Contact BFA Law before the Imminent July 14 Class Action Deadline

Jun 30, 2025 12:43PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 30, 2025 12:02PM Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)

Jun 29, 2025 08:18AM IOVA CLASS DEADLINE: Iovance Biotherapeutics Shareholders that Suffered Losses are Reminded to Contact BFA Law by Upcoming July 14 Court Deadline

Jun 29, 2025 07:56AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 28, 2025 11:52AM IOVA FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class

Jun 27, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jun 27, 2025 12:00PM Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Action Against Iovance Biotherapeutics, Inc. (IOVA)

Jun 27, 2025 11:30AM IOVA DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securit

Jun 27, 2025 08:46AM IOVA DEADLINE: BFA Law Reminds Iovance Biotherapeutics Investors with Losses to Submit their Information before July 14 Class Action Deadline

Jun 25, 2025 03:36PM IOVA SECURITIES ALERT: Iovance Biotherapeutics Investors are Notified to Contact BFA Law before the Upcoming July 14 Class Action Deadline

Jun 25, 2025 12:02PM Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Action Against Iovance Biotherapeutics, Inc. (IOVA)

Jun 25, 2025 10:28AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 24, 2025 03:22PM Iovance Biotherapeutics, Inc. Investors are Notified to Contact BFA Law by July 14 Deadline to Potentially Recover Losses in Securities Fraud Class Action

Jun 24, 2025 01:36PM Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman

Jun 23, 2025 03:18PM IOVANCE FRAUD: BFA Law Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors with Losses to Contact the Firm Prior to the July 14 Class Action Deadline

Jun 23, 2025 12:02PM Scott+Scott Attorneys at Law LLP Reminds Investors Of The Class Action That Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)

Jun 23, 2025 10:06AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 22, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jun 22, 2025 09:15AM ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA

Jun 22, 2025 08:54AM IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Jun 21, 2025 08:33AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 21, 2025 08:30AM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA

View Older Stories